Login to Your Account



Genfit, Sanofi-Aventis Ink $54M Deal for Metabolic Disorders

By Marie Powers


Friday, March 18, 2011
Extending a partnership that dates back to 1999, Genfit, of Lille, France, has inked an agreement with Sanofi-Aventis SA, of Paris, to pursue therapies for the treatment of metabolic disorders.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription